Studies are currently being done on pentoxilin an inhibitor of alpha TNF, caspase inhibitors, incretin analogs exenatide and sitagliptin, and second generation sulfonylureas repaglinide and nateglinide. In the future these might become options for treating NAFLD.
Estudios en desarrollo con pentoxifilina inhibidor TNF alfa, inhibidores de la caspasa, análogos de la incretina exenatide y sitagliptina, sulfonilureas de segunda generación repaglinide y nateglinide, podrían en un futuro ser opciones para los pacientes con NAFLD.